ADV
Q3 2026 EPS Estimate
$1.51
Aug 6, 2026 · Reports before open
Revenue Estimate
$887M
FY2027E EPS$1.51
FY2028E EPS$10.77

Analyst Sentiment

Wall St. Consensus
Hold
3 analysts·Low coverage
58
Score
1 Buy (33%)2 Hold (67%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
133%
Hold
267%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$18.75
-51.7%
Consensus
$18.75
-51.7%
Bull
$18.75
-51.7%
12-Month Target Range3 analysts
$18.75$18.75$18.75
Current $38.86Consensus
Current Price
$38.86
Above Consensus
$20.11

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+0.65%
EPS
FY2028
Rev-1.18%
EPS+613.25%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$3.58B$3.60B$3.56B
Low$3.56B$3.58B$3.54B
High$3.59B$3.62B$3.57B
EBITDA Avg$-109M$-110M$-109M
Low$-110M$-110M$-109M
High$-109M$-109M$-108M
EBIT Avg$-319M$-321M$-318M
Low$-321M$-323M$-319M
High$-318M$-320M$-316M
Net Income Avg$-33M$20M$140M
Low$-33M$19M$139M
High$-33M$20M$141M
EPS Avg$-2.52$1.51$10.77
Low$-2.54$1.50$10.71
High$-2.50$1.52$10.83
Analysts (Rev / EPS)1 / 11 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$916M$925M$879M$898M$929M$938M
Low$916M$925M$879M$898M$929M$938M
High$916M$925M$879M$898M$929M$938M
EBITDA Avg$-28M$-28M$-27M$-27M$-28M$-29M
Low$-28M$-28M$-27M$-27M$-28M$-29M
High$-28M$-28M$-27M$-27M$-28M$-29M
EBIT Avg$-82M$-83M$-78M$-80M$-83M$-84M
Low$-82M$-83M$-78M$-80M$-83M$-84M
High$-82M$-83M$-78M$-80M$-83M$-84M
Net Income Avg$9M$4M$-7M$6M$13M$4M
Low$9M$4M$-7M$6M$13M$4M
High$9M$4M$-7M$6M$13M$4M
EPS Avg$0.66$0.34$-0.56$0.42$0.96$0.28
Low$0.66$0.34$-0.56$0.42$0.96$0.28
High$0.66$0.34$-0.56$0.42$0.96$0.28
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Mar 3, 2026Morgan Stanley
Advantage Solutions Inc. (ADV) PT Lowered to $0.75 at Morgan Stanley
Target:$0.75
-94.5%from $13.73
Dec 17, 2025Morgan Stanley
Advantage Solutions price target lowered to $1.50 from $2 at Morgan Stanley
Target:$1.50
-92.9%from $21.11
May 14, 2025Morgan Stanley
Advantage Solutions price target lowered to $2 from $4.50 at Morgan Stanley
Target:$2.00
-92.9%from $28.00
May 13, 2022Morgan Stanley
Advantage Solutions Snaps Up Brandshare; Street Sees 46% Upside
Target:$6.00
-94.7%from $113.75
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.